1. Home
  2. SHOT vs LVTX Comparison

SHOT vs LVTX Comparison

Compare SHOT & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHOT
  • LVTX
  • Stock Information
  • Founded
  • SHOT 2018
  • LVTX 2016
  • Country
  • SHOT United States
  • LVTX Netherlands
  • Employees
  • SHOT N/A
  • LVTX N/A
  • Industry
  • SHOT Biotechnology: Pharmaceutical Preparations
  • LVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SHOT Health Care
  • LVTX Health Care
  • Exchange
  • SHOT Nasdaq
  • LVTX Nasdaq
  • Market Cap
  • SHOT 49.9M
  • LVTX 43.9M
  • IPO Year
  • SHOT 2020
  • LVTX 2021
  • Fundamental
  • Price
  • SHOT $1.26
  • LVTX $1.65
  • Analyst Decision
  • SHOT
  • LVTX Strong Buy
  • Analyst Count
  • SHOT 0
  • LVTX 2
  • Target Price
  • SHOT N/A
  • LVTX $6.00
  • AVG Volume (30 Days)
  • SHOT 697.6K
  • LVTX 33.9K
  • Earning Date
  • SHOT 11-14-2024
  • LVTX 11-14-2024
  • Dividend Yield
  • SHOT N/A
  • LVTX N/A
  • EPS Growth
  • SHOT N/A
  • LVTX N/A
  • EPS
  • SHOT N/A
  • LVTX N/A
  • Revenue
  • SHOT $1,025,549.00
  • LVTX $7,398,000.00
  • Revenue This Year
  • SHOT N/A
  • LVTX N/A
  • Revenue Next Year
  • SHOT N/A
  • LVTX N/A
  • P/E Ratio
  • SHOT N/A
  • LVTX N/A
  • Revenue Growth
  • SHOT 68.01
  • LVTX N/A
  • 52 Week Low
  • SHOT $0.55
  • LVTX $1.13
  • 52 Week High
  • SHOT $7.50
  • LVTX $6.47
  • Technical
  • Relative Strength Index (RSI)
  • SHOT 54.87
  • LVTX 46.15
  • Support Level
  • SHOT $1.18
  • LVTX $1.59
  • Resistance Level
  • SHOT $1.35
  • LVTX $1.75
  • Average True Range (ATR)
  • SHOT 0.11
  • LVTX 0.08
  • MACD
  • SHOT -0.01
  • LVTX 0.00
  • Stochastic Oscillator
  • SHOT 71.87
  • LVTX 41.18

About SHOT Safety Shot Inc.

Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.

About LVTX LAVA Therapeutics N.V.

LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.

Share on Social Networks: